Testing a stool test for Alzheimer’s markers
Part of Brain & nervous system, Mental health clinical trials.
This study checks if Alzheimer’s-related proteins (amyloid and tau) can be found in stool samples. It may help develop a simple, non-invasive way to detect Alzheimer’s disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older.
- You may have Alzheimer’s disease, mild or major cognitive issues, or be a healthy volunteer with no memory complaints.
- If you have memory or thinking problems, you need a specific diagnosis based on spinal fluid or clinical criteria.
- Healthy volunteers must score well on memory tests and have no cognitive complaints.
- You must understand the study and not be legally protected or without health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans or spinal fluid tests to confirm Alzheimer's-related changes. It aims to track the disease over time to better understand and improve care.
This study looks at how to better predict and understand Alzheimer's disease by using advanced brain scans and spinal fluid tests. It aims to find ways to identify people who stay healthy longer despite risk factors.
This study is looking for a simple blood test to help diagnose Alzheimer's disease earlier and more accurately in a primary care setting. If you are 55 or older with memory concerns, participating could help improve diagnostic methods and may lead to earlier support and treatment.
This study is testing whether a simple blood draw can help spot early signs of Alzheimer's disease. It aims to include people from diverse backgrounds who do not currently have memory problems, which may help make early detection more accessible for everyone.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study looks at how effective a treatment is in people newly diagnosed with mild to moderate Alzheimer’s disease. It also involves health and medication history checks and likely stool (fecal) sample collection to monitor effects.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.